Literature DB >> 16698747

Designing Spiegelmers to antagonise ghrelin.

P J Hornby1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16698747      PMCID： PMC1856213          DOI： 10.1136/gut.2005.076067

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Mirror-image RNA that binds D-adenosine.

Authors:  S Klussmann; A Nolte; R Bald; V A Erdmann; J P Fürste
Journal:  Nat Biotechnol       Date:  1996-09       Impact factor: 54.908

2.  Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats.

Authors:  P Kobelt; S Helmling; A Stengel; B Wlotzka; V Andresen; B F Klapp; B Wiedenmann; S Klussmann; H Mönnikes
Journal:  Gut       Date:  2005-06-30       Impact factor: 23.059

3.  ISIS 2302, an antisense inhibitor of intercellular adhesion molecule 1.

Authors:  W R Shanahan
Journal:  Expert Opin Investig Drugs       Date:  1999-09       Impact factor: 6.206

4.  Identification of D-peptide ligands through mirror-image phage display.

Authors:  T N Schumacher; L M Mayr; D L Minor; M A Milhollen; M W Burgess; P S Kim
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

5.  Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus.

Authors:  Lixin Wang; David H Saint-Pierre; Yvette Taché
Journal:  Neurosci Lett       Date:  2002-05-31       Impact factor: 3.046

6.  Distribution of ghrelin-immunoreactive cells in human gastric mucosa: comparison with that of parietal cells.

Authors:  Michiko Tanaka-Shintani; Makoto Watanabe
Journal:  J Gastroenterol       Date:  2005-04       Impact factor: 7.527

7.  Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus.

Authors:  Muhtashan S Mondal; Yukari Date; Hideki Yamaguchi; Koji Toshinai; Tomoko Tsuruta; Kenji Kangawa; Masamitsu Nakazato
Journal:  Regul Pept       Date:  2005-03-15

8.  Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer.

Authors:  Steffen Helmling; Christian Maasch; Dirk Eulberg; Klaus Buchner; Werner Schröder; Christian Lange; Stefan Vonhoff; Britta Wlotzka; Matthias H Tschöp; Stefan Rosewicz; Sven Klussmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

9.  Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins.

Authors:  Keith Rose; Lydie Bougueleret; Thierry Baussant; Günter Böhm; Paolo Botti; Jacques Colinge; Isabelle Cusin; Hubert Gaertner; Anne Gleizes; Manfred Heller; Silvia Jimenez; Andrew Johnson; Martin Kussmann; Laure Menin; Christoph Menzel; Frederic Ranno; Patricia Rodriguez-Tomé; John Rogers; Cedric Saudrais; Matteo Villain; Diana Wetmore; Amos Bairoch; Denis Hochstrasser
Journal:  Proteomics       Date:  2004-07       Impact factor: 3.984

10.  Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa.

Authors:  Yoshikatsu Nakai; Hiroshi Hosoda; Kazuko Nin; Chizuru Ooya; Hiromi Hayashi; Takashi Akamizu; Kenji Kangawa
Journal:  Eur J Endocrinol       Date:  2003-07       Impact factor: 6.664
  10 in total
  2 in total

Review 1.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

Review 2.  Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.

Authors:  Dante J Merlino; Erik S Blomain; Amanda S Aing; Scott A Waldman
Journal:  J Clin Med       Date:  2014-07-15       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.